Clinical trial
AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid…
NCT00180102 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00180102 |
|---|---|
| Title | AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years |
| Official title | AML2003 - Randomized Comparison Between Standard-Therapy and Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years. A Prospective, Randomized, Multi-center Therapy-Optimizing-Study. |
| Lead sponsor | Technische Universität Dresden, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Leukemia, Nonlymphocytic, Acute |
| Intervention type | Drug, Procedure |
| Interventions | Cytarabine vs. Cytarabine+Amsacrine+Mitoxantrone, early allogeneic PBSCT within induction therapy, autologous PBSCT |
| Enrollment | 600 |
| Start date | Dec 1, 2003 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 24, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: